ASND
$165.05
Revenue | $173.92Mn |
Net Profits | $-38.47Mn |
Net Profit Margins | -22.12% |
Ascendis Pharma A/s’s revenue jumped 81.36% since last year same period to $173.92Mn in the Q4 2024. On a quarterly growth basis, Ascendis Pharma A/s has generated 200.72% jump in its revenue since last 3-months.
Ascendis Pharma A/s’s net profit jumped 70.64% since last year same period to $-38.47Mn in the Q4 2024. On a quarterly growth basis, Ascendis Pharma A/s has generated 61.22% jump in its net profits since last 3-months.
Ascendis Pharma A/s’s net profit margin jumped 83.81% since last year same period to -22.12% in the Q4 2024. On a quarterly growth basis, Ascendis Pharma A/s has generated 87.1% jump in its net profit margins since last 3-months.
EPS Estimate Current Quarter | -0.93 |
EPS Estimate Current Year | -0.93 |
Ascendis Pharma A/s’s earning per share (EPS) estimates for the current quarter stand at -0.93 - a 50.65% jump from last quarter’s estimates.
Ascendis Pharma A/s’s earning per share (EPS) estimates for the current year stand at -0.93.
Earning Per Share (EPS) | -0.64 |
Ascendis Pharma A/s’s earning per share (EPS) jumped 58.44% since last year same period to -0.64 in the Q4 2024. This indicates that the Ascendis Pharma A/s has generated 58.44% annual rate of jump in its earning per share (EPS) in the last 4 quarters.
Earnings Date | Estimated EPS | Reported EPS | Surprise % |
---|---|---|---|
2024-09-30 | -1.89 | -1.72 | 8.99% |
2024-05-02 | -1.5 | -2.3 | -53.33% |
2025-02-12 | -0.93 | -0.64 | 31.38% |